- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Dr. Axel J. Schilder
News 26 results
In the News · Source: JUVE Steuermarkt
April 19, 2023
Axel Schilder comments on the current transaction market in Germany
In the News · Source: Deutscher AnwaltSpiegel
April 12, 2023
Axel Schilder discusses diversity & lawyer-well-being at Juracon panel
In the News · Source: Immobilien Zeitung, Institutional Money, Deal Magazine and Property Magazine
March 23, 2023
King & Spalding Frankfurt collaborates with x-project on ESG compliance report for funds and other real estate holders
Recognition
January 20, 2023
King & Spalding Real Estate Team and Counsel Moritz Heidbuechel Honored by WirtschaftsWoche
Events 17 results
Speaking Engagement
June 19, 2023
Axel Schilder, Martin Wolff to Speak at 9th Tax Summit
Speaking Engagement
April 4, 2023
Axel Schilder to Speak at JURAcon
Conference
Speaking Engagement
June 9, 2022
Axel Schilder to Speak at 8th Tax Summit
Insights 18 results
Newsletter
June 1, 2021
ESG Spezial - June 2021
Article
March 31, 2021
Immobilienkapitalmarkt 2021
Article
September 22, 2017
Immobilienkapitalmarkt 2017
Client Alert
December 15, 2016
(Teil)Entwarnung für SPV-Finanzierungen – BaFin veröffentlicht Auslegungshilfe zum Abschirmungsgesetz